Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. logo
SRPT

Sarepta Therapeutics, Inc. (SRPT)

$1191.04%

Market is closed
– opens on 8 PM, 06 Feb 2023
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$118.85
Day's Range
$121.05
$61.28
52-Week Range
$134.08
1 month return2.15%
3 month return18.54%
1 year return56.68%
5 year return96.37%

Analyst Recommendation

based on 27 analysts ratings

Buy
77%
Buy
22%
Hold
0%
Sell

Based on 27 Wall street analysts offering stock ratings for Sarepta Therapeutics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 26.89%

Current

$119.0

Target

$151.0

Recommendation Trend

Based on 27 analyst

Current1M Ago3M Ago
Buy
21
16
21
Hold
6
5
6
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization10.7B
Book Value$4.91
Dividend Share0.0
Dividend Yield0.0%
Earnings Per Share (EPS)-4.28
PEG Ratio159.25
Wall Street Target Price151.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)25.74
Enterprise Value10.6B
Enterprise Value/Revenue12.09
Enterprise Value/Ebitda-17.47

Technicals

Beta1.01
50 Day MA122.54
200 Day MA99.95

Institutional Holdings

Vanguard Group Inc

9.21%

HHG PLC

7.38%

BlackRock Inc

6.08%

venBio Select Advisor LLC

3.62%

EcoR1 Capital, LLC

3.42%

Wellington Management Company LLP

2.92%

Company Information

Sarepta Therapeutics Inc. is leading a revolution in precision genetic medicine and every day is an opportunity to change the lives of people living with raredisease. The Company has built an impressive position in Duchenne muscular dystrophy (DMD) and in gene therapies for limb-girdle muscular dystrophies (LGMDs), mucopolysaccharidosis type IIIA, Charcot-Marie-Tooth (CMT), and other CNS-related disorders, with more than 40 programs in various stages of development. The Company's programs and research focus span several therapeutic modalities, including RNA, gene therapy and gene editing.
OrganizationSarepta Therapeutics, Inc.
Employees840
CEOMr. Douglas S. Ingram Esq.
IndustryHealth Technology

Discover more

Frequently Asked Questions

What is Sarepta Therapeutics, Inc. share price today?

Can Indians buy Sarepta Therapeutics, Inc. shares?

How can I buy Sarepta Therapeutics, Inc. shares from India?

Can Fractional shares of Sarepta Therapeutics, Inc. be purchased?

What are the documents required to start investing in Sarepta Therapeutics, Inc. stocks?

What are today’s High and Low prices of Sarepta Therapeutics, Inc.?

What are today’s traded volumes of Sarepta Therapeutics, Inc.?

What is today’s market capitalisation of Sarepta Therapeutics, Inc.?

What is the 52 Week High and Low Range of Sarepta Therapeutics, Inc.?

How much percentage Sarepta Therapeutics, Inc. is down from its 52 Week High?

How much percentage Sarepta Therapeutics, Inc. is up from its 52 Week low?

What are the historical returns of Sarepta Therapeutics, Inc.?

Who is the Chief Executive Officer (CEO) of Sarepta Therapeutics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*